Clinical Trial Update: A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations [Phase 1, Phase 2]

View source ↗

Summary

An early-stage clinical trial evaluating the safety and potential benefits of an ear injection of Paliroden for cochlear synaptopathy, conducted in Phase 1 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cochlear Synaptopathy

Drugs mentioned

• Paliroden

Snippet

Sponsor: Cilcare SAS | Conditions: Cochlear Synaptopathy | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING